Cas 1034890-97-5,5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-1H-pyrazole-3-carboxamide

1034890-97-5

Post Buying Request

Basic information

Product Name: 5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-1H-pyrazole-3-carboxamide
Synonyms: 5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-1H-pyrazole-3-carboxamide
CAS NO:1034890-97-5
Molecular Formula:
Molecular Weight: 469.414
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-1H-pyrazole-3-carboxamide(CAS DataBase Reference)
NIST Chemistry Reference: 5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-1H-pyrazole-3-carboxamide(1034890-97-5)
EPA Substance Registry System: 5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-yl-1H-pyrazole-3-carboxamide(1034890-97-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1034890-97-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1034890-97-5 Suppliers

Recommended suppliers

1034890-97-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1034890-97-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,4,8,9 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1034890-97:
(9*1)+(8*0)+(7*3)+(6*4)+(5*8)+(4*9)+(3*0)+(2*9)+(1*7)=155
155 % 10 = 5
So 1034890-97-5 is a valid CAS Registry Number.

1034890-97-5Upstream product

1034890-97-5Downstream Products

1034890-97-5Relevant academic research and scientific papers

NOVEL CB1 ANTAGONISTS AND THEIR PREPARATION

-

Page/Page column 15, (2008/12/06)

The invention relates to new compounds of general formula (I) acting as CB1 antagonists and to their preparation. The compounds according to this invention can be used for the treatment of obesity, behavioral addictions, psychiatric and metabolic disorder

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1034890-97-5